Nicotine Intake in Adult Pod E-cigarette Users: Impact of User and Device Characteristics.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
14 Jul 2023
Historique:
received: 23 09 2022
revised: 13 01 2023
accepted: 14 04 2023
pmc-release: 15 04 2024
medline: 17 7 2023
pubmed: 17 4 2023
entrez: 16 4 2023
Statut: ppublish

Résumé

This study examined user behavior, e-cigarette dependence, and device characteristics on nicotine intake among users of pod-mod e-cigarettes. In 2019-2020, people who use pod-mods in the San Francisco Bay Area completed questionnaires and provided a urine sample for analysis of total nicotine equivalents (TNE). The relationship between TNE and e-cigarette use, e-cigarette brands, e-liquid nicotine strength, e-cigarette dependence, and urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), as a measure of combustible cigarette exposure, were examined. Of 100 participants (64% male, 71% in the 18-34 age group, 45% white), 53 used JUUL primarily, 12 used Puff Bar primarily, and 35 used other brands, including Suorin; 48 participants reported current cigarette smoking. Participants most often reported use of e-liquid with 4.5%-6.0% nicotine (68%), fruit (35%), tobacco (28%), and menthol or mint flavors (26%), used e-cigarettes on 25.5 (SD = 6.3) days a month, 10.2 (SD = 14.2) times a day, and 40% used 1-2 pods/cartridges per week. In bivariate analysis, urinary TNE was higher with greater frequency (days used) and intensity (number of pods used) of e-cigarette use, e-cigarette dependence, and combustible cigarette use. In multivariable analysis, days of e-cigarette use in the last 30 days, number of pods used per week, and NNAL levels were significantly associated with TNE. There was no significant impact of e-liquid nicotine strength on TNE. Nicotine intake among people who used pod-mod e-cigarettes increased with e-cigarette consumption and e-cigarette dependence, but not with e-liquid nicotine strength. Our findings may inform whether FDA adopts a nicotine standard for e-cigarettes. The study examined how device and user characteristics influence nicotine intake among pod-mod e-cigarette users. Nicotine intake increased with frequency (days of e-cigarette use in past 30 days) intensity of use (number of pods used per day) and e-cigarette dependence but not with the flavor or nicotine concentration of the e-liquids. Regulation of nicotine concentration of e-liquids is unlikely to influence nicotine exposure among adult experienced pod-mod users.

Identifiants

pubmed: 37061820
pii: 7123536
doi: 10.1093/ntr/ntad050
pmc: PMC10347964
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1489-1495

Subventions

Organisme : NIDA NIH HHS
ID : P30 DA012393
Pays : United States
Organisme : NHLBI NIH HHS
ID : U54 HL147127
Pays : United States
Organisme : NHLBI NIH HHS
ID : 1 U54HL147127
Pays : United States
Organisme : NIH HHS
Pays : United States

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Addict Behav. 2022 Jan;124:107117
pubmed: 34555560
Nicotine Tob Res. 2023 Feb 9;25(3):498-504
pubmed: 36073762
Nicotine Tob Res. 2020 Jun 12;22(7):1239-1243
pubmed: 31821492
JAMA Pediatr. 2020 Jul 1;174(7):714-720
pubmed: 32478809
Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3421-5
pubmed: 19959691
Toxicol Lett. 2007 Sep 10;173(2):101-6
pubmed: 17716838
Qual Health Res. 2021 Mar;31(4):703-712
pubmed: 33213262
Nicotine Tob Res. 2018 Jul 9;20(8):998-1003
pubmed: 29065196
Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):254-261
pubmed: 29475963
Nicotine Tob Res. 2023 Feb 9;25(3):412-420
pubmed: 35965260
Addiction. 2022 Jan;117(1):207-215
pubmed: 34105208
Addiction. 2020 Jun;115(6):1141-1148
pubmed: 31994254
Drug Alcohol Depend. 2019 Aug 1;201:85-93
pubmed: 31200279
Tob Control. 2019 Mar;28(2):146-151
pubmed: 29853561
Nicotine Tob Res. 2020 Feb 6;22(2):288-292
pubmed: 30852610
MMWR Morb Mortal Wkly Rep. 2021 Oct 01;70(39):1387-1389
pubmed: 34591834
Chem Res Toxicol. 2001 Nov;14(11):1465-81
pubmed: 11712903
Nicotine Tob Res. 2004 Apr;6(2):199-205
pubmed: 15203793
N Engl J Med. 2020 Feb 20;382(8):689-691
pubmed: 31951683
Nicotine Tob Res. 2015 Feb;17(2):186-92
pubmed: 25332459
Addiction. 2018 Oct;113(10):1874-1882
pubmed: 29882257
N Engl J Med. 2018 Sep 20;379(12):1099-1102
pubmed: 30134127

Auteurs

Jeremy Giberson (J)

Research Program in Clinical Pharmacology, Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.

Natalie Nardone (N)

Research Program in Clinical Pharmacology, Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.

Newton Addo (N)

Research Program in Clinical Pharmacology, Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.

Sameera Khan (S)

Univiersity of California, Berkeley, CA, USA.

Peyton Jacob (P)

Research Program in Clinical Pharmacology, Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.
Center for Tobacco Control Research and Education, University of California, San Francisco, CA, USA.
Tobacco Center of Regulatory Science, University of California, San Francisco, CA, USA.

Neal Benowitz (N)

Research Program in Clinical Pharmacology, Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.
Center for Tobacco Control Research and Education, University of California, San Francisco, CA, USA.
Tobacco Center of Regulatory Science, University of California, San Francisco, CA, USA.

Gideon St Helen (G)

Research Program in Clinical Pharmacology, Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.
Center for Tobacco Control Research and Education, University of California, San Francisco, CA, USA.
Tobacco Center of Regulatory Science, University of California, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH